Ardent Health authorizes $50M share repurchase program; $609M cash on hand

Ardent Health, Inc.

Board authorized up to $50M in common stock repurchases; no expiration date.
CEO Marty Bonick cites conviction in business fundamentals and strong balance sheet.
Q3 2025 liquidity: $609M cash, lease-adjusted net leverage of 2.5x.
Program funded from existing cash; does not affect ability to pursue M&A or growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.